Compare ALLO & ALCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALLO | ALCO |
|---|---|---|
| Founded | 2017 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.9M | 267.7M |
| IPO Year | 2018 | N/A |
| Metric | ALLO | ALCO |
|---|---|---|
| Price | $1.80 | $40.82 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $8.27 | N/A |
| AVG Volume (30 Days) | ★ 6.3M | 27.2K |
| Earning Date | 03-12-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 0.49% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $29,059,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.86 | $27.02 |
| 52 Week High | $3.78 | $43.20 |
| Indicator | ALLO | ALCO |
|---|---|---|
| Relative Strength Index (RSI) | 58.49 | 58.23 |
| Support Level | $1.56 | $40.60 |
| Resistance Level | $1.84 | $41.66 |
| Average True Range (ATR) | 0.16 | 1.31 |
| MACD | -0.01 | -0.18 |
| Stochastic Oscillator | 67.96 | 26.32 |
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.
Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.